Lactobacillus strains isolated from infant faeces possess potent inhibitory activity against intestinal alpha- and beta-glucosidases suggesting anti-diabetic potential
出版年份 2014 全文链接
标题
Lactobacillus strains isolated from infant faeces possess potent inhibitory activity against intestinal alpha- and beta-glucosidases suggesting anti-diabetic potential
作者
关键词
<em class=EmphasisTypeItalic >Lactobacillus</em>, Alpha-glucosidase, Beta-glucosidase
出版物
EUROPEAN JOURNAL OF NUTRITION
Volume 53, Issue 7, Pages 1465-1474
出版商
Springer Nature
发表日期
2014-01-11
DOI
10.1007/s00394-013-0649-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- α-Amylase Inhibitors: A Review of Raw Material and Isolated Compounds from Plant Source
- (2016) Paloma Michelle Sales et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Antiviral therapies targeting host ER alpha-glucosidases: Current status and future directions
- (2013) Jinhong Chang et al. ANTIVIRAL RESEARCH
- The role of co-morbidity in the selection of antidiabetic pharmacotherapy in type-2 diabetes
- (2013) Diethelm Tschöpe et al. Cardiovascular Diabetology
- Enzymatic Properties of a Thermostable α-Glucosidase from Acidothermophilic Crenarchaeon Sulfolobus tokodaii Strain 7
- (2013) Jung-Eun Park JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY
- Mini-Special Issue paper Management of diabetic patients with hypoglycemic agents α-Glucosidase inhibitors and their use in clinical practice
- (2012) Giuseppe Derosa et al. Archives of Medical Science
- Potent α-glucosidase and α-amylase inhibitory activities of standardized 50% ethanolic extracts and sinensetin from Orthosiphon stamineus Benth as anti-diabetic mechanism
- (2012) Elsnoussi Ali Hussin Mohamed et al. BMC Complementary and Alternative Medicine
- The complete genome sequence of the acarbose producer Actinoplanes sp. SE50/110
- (2012) Patrick Schwientek et al. BMC GENOMICS
- Efficacy and Safety Profile Evaluation of Acarbose Alone and in Association With Other Antidiabetic Drugs: A Systematic Review
- (2012) Giuseppe Derosa et al. CLINICAL THERAPEUTICS
- Alpha-glucosidase inhibitors 2012 – cardiovascular considerations and trial evaluation
- (2012) Eberhard Standl et al. Diabetes & Vascular Disease Research
- Probiotics as potential biotherapeutics in the management of type 2 diabetes - prospects and perspectives
- (2012) Harsh Panwar et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Production of the α-glycosidase inhibitor 1-deoxynojirimycin from Bacillus species
- (2012) Shinji Onose et al. FOOD CHEMISTRY
- A Meta-Analysis of Probiotic Efficacy for Gastrointestinal Diseases
- (2012) Marina L. Ritchie et al. PLoS One
- Expression and purification of two Family GH31 α-glucosidases from Bacteroides thetaiotaomicron
- (2012) Marcia M. Chaudet et al. PROTEIN EXPRESSION AND PURIFICATION
- Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations
- (2012) Christoph Rosak et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Screening for glycosidase activities of lactic acid bacteria as a biotechnological tool in oenology
- (2011) Fátima Pérez-Martín et al. WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY
- The Human Gut Microbiome: Ecology and Recent Evolutionary Changes
- (2010) Jens Walter et al. Annual Review of Microbiology
- Natural Products as α-Amylase and α-Glucosidase Inhibitors and their Hypoglycaemic Potential in the Treatment of Diabetes: An Update
- (2010) R. Tundis et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Effects of Lactobacillus acidophilus on gut microflora metabolic biomarkers in fed and fasted rats
- (2009) Konstantinos C. Mountzouris et al. CLINICAL NUTRITION
- Proteolytic Profiles and Angiotensin-I Converting Enzyme and α-Glucosidase Inhibitory Activities of Selected Lactic Acid Bacteria
- (2008) L. Ramchandran et al. JOURNAL OF FOOD SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started